Ayodele Odutayo
Overview
Explore the profile of Ayodele Odutayo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1590
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nardone M, Yau K, Kugathasan L, Odutayo A, Mohsen M, Ouimet J, et al.
Nephrol Dial Transplant
. 2025 Feb;
40(Supplement_1):i47-i58.
PMID: 39907540
Abstract: Despite recent advancements in the treatment of chronic kidney disease (CKD), identifying novel therapies beyond guideline-directed therapies that reduce residual cardiorenal risk remains imperative. In this review, we highlight...
2.
Sridhar V, Odutayo A
J Am Soc Nephrol
. 2025 Feb;
36(2):171-173.
PMID: 39899677
No abstract available.
3.
Sridhar V, Odutayo A, Garg S, Danne T, Doria A, Mauer M, et al.
J Am Soc Nephrol
. 2024 Nov;
PMID: 39485484
No abstract available.
4.
Odutayo A, Zinman B, Wanner C, Zwiener I, Lund S, Hantel S, et al.
CJC Open
. 2024 Jul;
6(7):868-875.
PMID: 39026628
Background: In patients with type 2 diabetes mellitus (T2DM), a history of an ischemic event is associated with increased risk for cardiovascular (CV) disease. Whether patients with T2DM and a...
5.
Odutayo A, Cosentino F, Pratley R, Dagogo-Jack S, McGuire D, Frederich R, et al.
Diabetes Obes Metab
. 2024 Jun;
26(8):3478-3481.
PMID: 38840474
No abstract available.
6.
Nardone M, Sridhar V, Yau K, Odutayo A, Cherney D
Nephrol Dial Transplant
. 2024 Mar;
39(9):1392-1403.
PMID: 38425090
Volume overload represents a hallmark clinical feature linked to the development and progression of heart failure (HF). Alleviating signs and symptoms of volume overload represents a foundational HF treatment target...
7.
Myette R, Lamarche C, Odutayo A, Verdin N, Canney M
Can J Kidney Health Dis
. 2024 Feb;
11:20543581241232472.
PMID: 38404647
Purpose Of Review: Cardiovascular (CV) disease is a major cause of morbidity and mortality for patients with glomerular disease. Despite the fact that mechanisms underpinning CV disease risk in this...
8.
Sridhar V, Bhatt D, Odutayo A, Szarek M, Davies M, Banks P, et al.
Clin J Am Soc Nephrol
. 2024 Jan;
19(5):557-564.
PMID: 38277468
Background: In the initial analysis of the Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk...
9.
Odutayo A, Smith K, Gosse C, Chang M, Isaacksz S, Chan C
Int J Integr Care
. 2023 Dec;
23(4):16.
PMID: 38107835
The COVID-19 pandemic has mandated a re-imagination of how healthcare is administered and delivered, with a view towards focusing on person-centred care and advancing population health while increasing capacity, access...
10.
Yau K, Odutayo A, Dash S, Cherney D
Can J Cardiol
. 2023 Jul;
39(12):1816-1838.
PMID: 37429523
Glucagon-like peptide-1 receptor agonists (GLP1RA) are incretin agents initially designed for the treatment of type 2 diabetes mellitus but because of pleiotropic actions are now used to reduce cardiovascular disease...